Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Feasibility of a Comprehensive Prehabilitation Program for Use in Benign Prostatic Hyperplasia Patients Undergoing Holmium Laser Enucleation of the Prostate

NCT07552961 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07552961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07552961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Feasibility of a Comprehensive Prehabilitation Program for Use in Benign Prostatic Hyperplasia Patients Undergoing Holmium Laser Enucleation of the Prostate
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
November 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, benign prostatic hyperplasia with lower urinary tract symptoms, benign prostatic hyperplasia with outflow obstruction